1.23
Health Sciences
‘Fast’ MRI detects breast cancers that 3-D mammograms may miss
Abbreviated MRI shortens the screening time and requires only three sequences, while traditional ultrasound’s limitations don’t detect cancer as reliably for women with higher breast density.
Priming the immune system to attack cancer
An international team, co-led by the School of Dental Medicine’s George Hajishengallis, showed how immune “training” transforms certain immune cells to target tumors.
Media’s reporting on gun violence does not reflect reality
A new study looks at media reports in three cities and finds half of victims were covered in the news, but a disproportionate amount of attention was given to less common circumstances and victims.
Direct-to-consumer COVID-19 testing
Concerns over direct-to-consumer COVID-19 tests may override the benefits, with issues of safety, efficacy, and ethics in question.
The role of data in a world reshaped by COVID-19
Experts across Penn share their insights on how data and data science affect their fields in the context of an ongoing pandemic.
Magnetic field and hydrogels could be used to grow new cartilage
Instead of using synthetic materials, a Penn Medicine study shows magnets could be used to arrange cells to grow new tissues.
Penn Nursing’s innovation ecosystem
In the past five years, the school has been intentional about creating an atmosphere that rewards risk-taking and supports failures. It’s led to story slams and accelerators and a shift to an innovation-centric mindset.
New insights into autoimmune disease
According to research by the School of Dental Medicine’s George Hajishengallis and colleagues, novel insights into a pathway that restrains the immune response opens up new avenues for treating inflammatory and autoimmune conditions.
Workplace wellness programs could improve if more personalized
In a program that used three different types of behavioral nudges, a Penn Medicine study showed significantly different results for people with different personal and psychological characteristics.
Penn Medicine votes, and so should you: How to vote safely in 2020
The Penn Medicine Votes initiative, and Penn Medicine’s partnership with VotER helps staff and patients navigate a safe way to vote either before or on Election Day.
In the News
Current, deadly U.S. coronavirus surge has peaked, researchers say
David Rubin of the Perelman School of Medicine and Children’s Hospital of Philadelphia said that while there’s been a decline in COVID-19 transmission rates in most parts of the country, it will take many weeks or months for the number of people getting sick and dying to fall. "It's going to take a while. There's going to be a long tail, unfortunately," he said.
FULL STORY →
Some COVID-19 mutations may dampen vaccine effectiveness
E. John Wherry and Drew Weissman of the Perelman School of Medicine spoke about how new variants of the novel coronavirus might respond to the existing COVID-19 vaccines. “We don’t want people thinking that the current vaccine is already outdated. That’s absolutely not true,” said Wherry. However, he warned, the mutations “do in fact reduce how well our immune response is recognizing the virus.”
FULL STORY →
Underselling the vaccine
Aaron Richterman of the Perelman School of Medicine said overemphasizing the COVID-19 vaccine’s imperfections and unknowns may do more harm than good. “Not being completely open because you want to achieve some sort of behavioral public health goal—people will see through that eventually,” he said.
FULL STORY →
Need a new knee or hip? A robot may help install it
Matthew Sloan of the Perelman School of Medicine spoke about the increase in hip and knee replacement surgeries in the past 20 years. “Among the older patients, the big driver is the desire to stay active,” he said.
FULL STORY →
Drug being tested at University of Pennsylvania to treat COVID-19 shows promise
Carl June of the Perelman School of Medicine spoke about cyclosporin, an inexpensive drug that may help prevent severe inflammation in hospitalized COVID-19 patients. “Hopefully, [FDA approval of the drug] would decrease the burden of patients in our hospitals,” June said.
FULL STORY →